In recent days, Barclays downgraded Medpace Holdings, citing sector concerns and a reassessment of risks and valuation for the clinical research company. Despite Medpace's recent strong financial ...
19hOpinion
Weekly Commentary: A Feature, Not A Bug
Companies borrowed a record $207B in the US investment-grade market in Sept., more than Wall Street's top underwriter of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback